Abstract. Tuberculosis (TB) is the leading cause of death among individuals infected with the hepatitis B virus (HBV). The study of the joint dynamics of HBV and TB present formidable mathematical challenges due to the fact that the models of transmission are quite distinct. We formulate and analyze a deterministic mathematical model which incorporates of the co-dynamics of hepatitis B and tuberculosis. Two sub-models, namely: HBV-only and TB-only sub-models are considered first of all. Unlike the HBV-only sub-model, which has a globally-asymptotically stable disease-free equilibrium whenever the associated reproduction number is less than unity, the TBonly sub-model undergoes the phenomenon of backward bifurcation, where a stable disease-free equilibrium co-exists with a stable endemic equilibrium, for a certain range of the associated reproduction number less than unity. Thus, for TB, the classical requirement of having the associated reproduction number to be less than unity, although necessary, is not sufficient for its elimination. It is also shown, that the full HBV-TB co-infection model undergoes a backward bifurcation phenomenon. Through simulations, we mainly find that i) the two diseases will co-exist whenever their partial reproductive numbers exceed unity; (ii) the increased progression rate due to exogenous reinfection from latent to active TB in co-infected individuals may play a significant role in the rising prevalence of TB; and (iii) the increased progression rates from acute stage to chronic stage of HBV infection have increased the prevalence levels of HBV and TB prevalences.
Introduction
Of the seven biggest killers worldwide, TB, malaria, hepatitis, and, in particular, HIV/AIDS continue to surge, with HIV/AIDS and TB likely to account for the overwhelming majority of deaths from infectious diseases in developing countries by 2020 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Sub-Saharan Africa accounting for nearly half of infectious disease deaths globally will remain the most vulnerable region. The death rates for many diseases, including HIV/AIDS, tuberculosis, malaria and hepatitis B, exceed those in all other regions. Sub-Saharan Africa's health care capacity, the poorest in the world, will continue to lag [4, 5] . Tuberculosis is an old disease whose world-wide prevalence had been diminishing even before vaccination and prophylaxis strategies were firstly accomplished. Its recent return in developing countries, mainly in Southeast Asia, have attracted renewed interest in it. The current world estimate of prevalence is about 33% while the number of deaths per year that it is causing reaches more than 3 million people [2] . Depending of the kind and the intensity of immune response that the host immune system performs after initial infection with M. tuberculosis bacillus, the individual can suffer latent infection, in which the bacteria are under a growth-arrest regime and the individual neither suffer any clinical symptom nor becomes infectious or active infection, where the host suffers clinical symptoms and can transmit the pathogen by air. Latently infected individuals can, generally after an immune-depression episode, reach the active phase. Estimating the probability of developing direct active infection after a contact, or alternatively, the lifetime's risk for a latent infected individual to evolve into the active phase, are not easy tasks. However, it is generally accepted that only 5-10% of the infections directly produce active TB, while the ranges concerning the estimation of typical "half-life" of latent state rounds about 500 years [4, 9] .
On the other hand, Hepatitis B is a disease caused by the hepatitis B virus (HBV) which infects the liver of hominoidae, including humans, and causes an inflammation called hepatitis. Originally known as "serum hepatitis", [3, 10] the disease has caused epidemics in parts of Asia and Africa [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . It can cause inflammation (swelling) of the liver, and sometimes significant liver damage. Many people do not even realize that they have been infected with that virus, because the typical flu-like symptoms may not develop immediately, or even at all. You can become infected with hepatitis B if you are not immune (resistant) to the virus and have been exposed to the blood or body fluids of an infected person. A vaccine is available to protect against hepatitis B. The hepatitis B virus is present in body fluids such as blood, saliva, semen and vaginal fluid. It can be passed from person to person through unprotected sex (without using a condom) or by sharing needles to inject drugs, for example. Hepatitis B is 100 times more infectious than HIV. Infected mothers can also pass the virus to their baby during childbirth, often without knowing that they are infected. The incubation period (the time it takes from coming into contact with the virus to developing infection) is between one and six months. About a third of the world's population, more than 2 billion people, have been infected with the hepatitis B virus [3] . This includes 350 million chronic carriers of the virus. In developing countries, it is estimated that 5 to 15% of persons are chronic carriers, whereas only about 1% of the population is chronically infected in North America and Western Europe [3, 10] .
It is important to emphasize that the occurrence of tuberculosis (TB), human immunodeficiency virus (HIV), and viral hepatitis infections in the same patient poses unique clinical and public health challenges, because medications to treat TB and HIV are hepatotoxic [21] . In developing countries, the scale up of HIV treatment takes place within overlapping epidemics of TB and HBV, particularly in populations where injection drug use and poverty are widespread. The presence of all three infections creates conditions for a perfect storm in medical management, as treatments for TB and HIV each affect the liver already weakened by HBV. In the southwest provinces and some areas of central China, and sub-Saharan Africa, for example, many patients present with all three infections, leading to unique challenges in their medical care [22] . Tuberculosis and hepatitis B are the two common co-infections in patients infected with HIV [21] [22] [23] [24] [25] [26] [27] . TB remains an important public health problem in the world that has been exacerbated by the HIV epidemic, resulting in increased morbidity and mortality worldwide. Successful treatment of tuberculosis patients with viral hepatitis and HIV co-infection is a challenging task. The symbiotic relationship between HBV and TB is a double blow to developing countries and in particular sub-Saharan Africa regions because of the high prevalence of TB and incidence of HBV. HBV and TB exhibit a unique symbiosis, despite biological differences. Therefore, there is a need for a strong qualitative assessment of the population-level implication of the consequences due to the interaction of these two diseases. Tuberculosis and HBV have become a major public health problem and show a danger mark even for the future generations, especially in Asian and sub-Saharan Africa. The main interest in studying HBV and TB model is to understand the long and short term behavior of the dynamics of both diseases and to predict whether the diseases will die out or will persist. A brief survey on previous studies provides the context of this paper.
Blal, et al. [21] studied the prevalence of hepatitis B virus infection among tuberculosis patients with and without HIV in Rio de Janeiro (Brazil). They showed that hepatitis B infection is highly prevalent in tuberculosis patients in Brazil and they suggested that a vaccination program for the general population should be considered in order to prevent further hepatitis B infections. In [22] , the authors studied the risk factors and algorithms to identify hepatitis C, hepatitis B, and HIV among Georgian tuberculosis patients. They recruited 300 individuals at in-patient tuberculosis hospitals in three cities in Georgia, administered a behavioral questionnaire, and tested for antibody to HIV, hepatitis C (HCV), hepatitis B core antigen (anti-HBc), and the hepatitis B surface antigen (HBsAg). They found that HIV infection was rare but HBV and HCV infections were common among Georgian tuberculosis patients. High and increasing prevalence of HBV has been reported among both tuberculosis patients and blood donors in Georgia between 1998 and 2001. But this study was the first to indicate that HBV is a significant problem among patients with tuberculosis in Georgia. Bellamy et al. [23] analyzed the co-infection of tuberculosis and chronic hepatitis B virus infection in Africans. They found that persons with VDR genotype tt may be resistant to TB and persistence of HBV infection.
The study of infectious disease co-epidemics is critical for understanding how the diseases are related, and how prevention and treatment efforts can be most effective. Mathematical models can provide insight into the complicated infection dynamics, and into effective control measures. Most mathematical epidemic models evaluate a single disease [28, 29] , although a growing number of studies have considered co-epidemics. Mathematical studies of co-infection models are not very common. There are a few co-infection models (cf. [30] [31] [32] [33] [34] [35] [36] [37] ) in the literature. Nevertheless, Naresh, et al. [31] developed a nonlinear mathematical model for TB/HIV co-infection. Bacaer, et al. [33] developed a mathematical model for the joint dynamics of HIV and TB using numerical simulations to estimate parameters and predict the future transmission of TB in a South Africa township. Sharomi et al. [34] analyzed a mathematical model of the transmission dynamics of HIV/TB co-infection in the presence of treatment, while Mukandavire et al. [35] study a model for HIV-malaria co-infection. In [36] , Expeditho, et al. presented an mathematical analysis of malaria and tuberculosis co-dynamics. Roeger, et al. [37] studied HIV/TB co-infection using a mathematical model which does not preclude the possibility of joint infections.
In this paper, we formulate and analyze a realistic mathematical model for HBV-TB co-infection, which incorporates the key epidemiological and biological features of each of the two diseases. The main contribution of this study is to carry out a detailed qualitative analysis of the resulting model. It is our view that this study represents the very first modelling work that provides an in-depth analysis of the qualitative dynamics of HBV-TB co-infection
The rest of this paper is organized as follows. The model is formulated in Section 2. The sub-models for HBV and TB are presented and analyzed in Sections 3. The analysis of the full HBV-TB co-infection model is carried out in Section 4. Numerical results are presented to illustrate the analytical results. Finally, section 5 contains concluding remarks.
Modeling of tuberculosis and HBV co-dynamics

Model construction
The formulation of this co-infection closely follows the epidemiological dynamics of the two diseases.
Basic framework
The model sub-divides the total population at time t denoted by N (t), into various mutuallyexclusive compartments depending on their disease status: Susceptible individuals to both diseases (S(t)), immune individuals following vaccination to HBV disease (V (t)), individuals with latent TB, E T (t), individuals with active TB (I T (t)), individuals with HBV acute infection (I H (t)), HBV chronic carriers (C H (t)), HBV recovered individuals with protective immunity (R H (t)) duallyinfected individuals with HBV acute infection, in the TB latent stage (E T I (t)), dually-infected individuals with HBV acute infection, in the TB active stage (I T I (t)), dually-infected individuals with HBV chronic carrier, in the TB latent stage (E T C (t)), dually-infected individuals with HBV chronic carrier, in the TB active stage (I T C (t)), HBV recovered individuals with protective immunity in the TB latent stage (E T R (t)) and HBV recovered individuals with protective immunity in the TB active stage (I T R (t)).
The total population is
The compartmental diagram in Fig. 1 illustrates the flow of individuals as they face the possibility of acquiring specific-disease infections or even co-infections.
The model is based on the following assumptions. The mixing between individuals is homogeneous. The population of individuals infected with active-TB is only generated from latent TB class following infection. Latently infected individuals are assumed to acquire some immunity as a result of infection, which reduces the risk of subsequent infection but does not fully prevent it. HBV carrier mothers can pass the virus to their baby during the childbirth. The vaccine-induced immunity acquired by vaccinated individuals is supposed to wane and the way for vaccinated individuals to acquire HBV infection is through the waning of vaccine-induced protection, and individuals therefore enter the HBV acute infection class.
All HBV infected individuals (those in the I H , C H and R H classes) are susceptible to TB infection and TB infected individuals (those in the E T and I T classes) are susceptible to HBV infection. Dually infected individuals with TB in the acute and chronic stage of HBV infection (those in the E T I , I T I , E T C and I T C classes) are assumed to transmit HBV at the same rate λ H as those with only HBV infection (I H or C H class). Individuals in the I T I , I T C and I T R classes can transmit TB at the same rate λ T as individuals with active TB alone (I T class). Susceptible and HBV vaccinated individuals acquire TB infection following effective contact with TB-infected individuals in the infectious stage (at rate λ T ). Also, susceptible who have never been successfully vaccinated, or who have been vaccinated but the protective effect of vaccination worn off acquire infection with HBV following effective contact with individuals in the acute and chronic carriers stage of HBV infection (at rate λ H ).
The force of infection associated with the HBV infection, denoted by λ H , is given by
where β H is the effective contact rate for HBV infection (contact sufficient to result in HBV infection), the modification parameter η 1 ≥ 1 accounts for the relative infectiousness of individuals with HBV acute infection in the TB latent stage (E T I ) or displaying active TB (I T I ) in comparison to those with HBV infection alone but with acute infection (I H ). In other words, it is assumed that HBV-infected individuals (with acute infection) who are also infected with TB are more infectious than HBV-infected individuals with acute infection and no TB infection (similar comparisons are made for HBV chronic carriers alone in relation to those with HBV chronic carriers and TB infection). infection alone. This is due to the fact that individuals in the acute stage of HBV infection have higher viral load compared to individuals in the chronic stage of HBV infection(this is owing to the aforementioned correlation between HBV viral load and infectiousness). Also, η 2 models the relative infectiousness of dually-infected individuals with chronic infection of HBV in the latent stage of TB (E T C ) or displaying active TB (I T C ) in comparison to those with HBV chronic infec-tion alone (C H ). Finally, η 2c (with η 2c ≥ η 2 ) is the modification parameter accounting the fact that dually-infected individuals with HBV chronic infection, but displaying active TB (I T C ), are more infectious than the corresponding dually-infected individuals with HBV chronic infection in the TB latent stage (E T C ). Similarly, susceptible and HBV vaccinated individuals acquire TB infection following contact with people in the active stage of TB (that is, those in I T , I T I , I T C and I T R classes) at rate λ T defined as follows:
where β T is the contact rate associated with the TB infection. The modification parameter ε > 1 accounts for the relative risk of infectiousness of dually-infected individuals in the active-TB classes (I T I , I T C and I T R ) in comparison to those in the only active TB class (I T ). Further, the modification parameter ε t (with ε t > ε > 1) accounting to the fact that dually-infected individuals with HBV acute infection, but displaying that active TB (I T I ) are more infectious than the corresponding HBV recovered individuals in the TB active stage (I T R ). Finally, ε c (with ε c ≥ ε t > 1) accounts for the assumed increase in infectiousness for dually-infected individuals in the chronic stage of HBV infection, but displaying active TB (I T C ), compared to dually-infected individuals with HBV acute infection in the TB active stage (I T I ). We define by ω the proportion of births without successful vaccination. Children born by carrier mothers (in the C H , E T C and I T C classes) who are unsuccessfully immunized by vaccination or have not been vaccinated can be infected by carrier mothers and will enter the C H , E T C and I T C classes at rates µω, µωv 1 and µωv 2 , respectively.
The susceptible class is generated by the recruitment of individuals into the population from immigration and children born by carrier women without successful vaccination who have not been infected by the HBV virus at the rates, Λ and µω (1− 
, respectively. The HBV vaccinated population increases by births who are successful immunized, and are protected from perinatal and postnatal infection at rate µ(1 − ω). Every susceptible vaccinated neonate enters the vaccinated class V at rate δ, representing the assumption that vaccination prevents perinatal transmission from infectious women. We assume that this protection is not lifelong. Further, natural death rate occurs in all compartments at the rate µ 0 .
Individuals with latent TB who have been infected with Mycobacterium tuberculosis but have no clinical symptoms/illness and are non-infectious. Fraction p of newly infected susceptible individuals is assumed to undergo a fast progression directly to the infectious class I T , while the remainder is latently infected and enter the latent class E T . Similarly, a fraction f of HBV vaccinated individuals who acquire TB infection move to the TB latent class (E T ), while the remaining fraction, 1 − f , enters the TB active class (I T ). Once latently infected with M. Tuberculosis, an individual will remain so for life unless reactivation occurs. To account for treatment, we define by r 1 E T the fraction of latently infected individuals receiving effective chemoprophylaxis, and r 2 as the rate of effective per capita therapy of individuals in the active TB alone. Chemoprophylaxis of latently infected individuals reduces their reactivation at the rate r 1 and the initiation of therapeutics immediately removes individuals from active status I T and places them into a latent state E T at the rate r 2 . Due to endogenous reactivation, a fraction 1 − r 1 of latently infected individuals who did not received effective chemoprophylaxis become infectious with a rate k, and some become reinfected (exogenously) after effective contact with individuals in the active TB classes only at rate σλ T . σ models the factor reducing the risk of infection as a result of acquiring immunity for latently infected individuals. Individuals with active-TB alone suffer a disease-induced death rate d T .
The population of individuals infected with TB only (in the E T or I T class) is also reduced following acquisition of HBV-infection, which can result following effective contacts with individuals in the HBV acute and chronic infection stage (in the I H , C H , E T I , E T C , I T I and I T C classes). Individuals exposed to TB can be infected with HBV (at a rate λ H ). That is, individuals in the E T class are moved into the E T I class upon acquiring HBV infection at rate ϕ 1 λ H where ϕ 1 accounts for the assumed increase in the probability of acquiring HBV infection for TB latently infected individuals only. Furthermore, individuals in the active stage of TB infection alone can acquire HBV infection, at rate ϕ 2 (1 − r 2 )λ H where ϕ 2 (with ϕ 2 > ϕ 1 ) models the probability of acquiring HBV infection for individuals in the active stage of TB infection alone. Individuals in the E T I class progress to the E T C and E T R classes at rates q 2 φ 2 and φ 2 (1 − q 2 ), respectively, where q 2 is the average probability that an individual in the E T I class fails to clear an acute infection and develops a carrier state (E T C ). Similarly, individuals in the I T I class progress to the I T C and I T R classes at rates q 1 φ 1 and φ 1 (1 − q 1 ), respectively, where q 1 is the average probability that an individual in the I T I class fails to clear an acute infection and develops a carrier state (I T C ). Dually infected individuals with HBV acute and chronic infection, and HBV recovered individuals in the TB latent stage are assumed to receive effective chemoprophylaxis at rates r 1h , r 1c and r 1r (with r 1r > r 1h > r 1c ), respectively.
Dually infected individuals with HBV acute and chronic infection, and HBV recovered individuals in the TB latent stage (in the E T I , E T C and E T R classes) who did not receive effective chemoprophylaxis can develop an active TB and will move to the I T I , I T C and I T R classes at rates k h (1 − r 1h ), k c (1 − r 1c ) and k r (1 − r 1r ) for endogenous reactivation and σ h λ T , σ c λ T and σ r λ T for exogenous re-infection, respectively. σ h , σ c and σ r are respectively, the factors reducing the risk of infection as a result of acquiring immunity for individuals in the E T I , E T C and E T R classes. The initiation of therapeutics immediately removes individuals from active status I T I , I T C and I T R and places them into latent states E T I , E T C and E T R at rates r 2h , r 2c and r 2r (with r 2r > r 2h > r 2c ), respectively. Furthermore, individuals in the I T I and I T R classes die due to TB at rates d 1T and d 3T (with d 1T > d 3T ), respectively, while, individuals in the E T C class die due to HBV at rate d 4T . In addition, individuals in the I T C class suffer death due to TB and HBV at rate d 2T (with
We point out that since the chemoprophylaxis of latently infected individuals only reduces their reactivation to active TB, chemoprophylaxis of dually-infected individuals with latent TB and HBV infection (those in the E T , E T I and E T C classes) have no effect on the progression of the HBV infection. This is why there, the terms 1 − r 1 , 1 − r 1h and 1 − r 1c which are associated to the chemoprophylaxis of individuals in the E T , E T I and E T C classes do not exist in the expressions of the transfer rates from E T to E T I , from E T I to E T C and from E T C to E T R , respectively. Dually-infected individuals with HBV acute infection in the TB latent stage I T I (t) Dually-infected individuals with HBV acute infection that displaying active TB E T C (t)
Dually-infected individuals with HBV chronic carrier in the TB latent stage I T C (t) Dually-infected individuals with HBV chronic carrier that displaying active TB
HBV recovered individuals with protective immunity in the TB latent stage I T R (t) HBV recovered individuals with protective immunity that displaying active TB
HBV recovered individuals with protective immunity Susceptible individuals whose HBV vaccination was successful enter in the HBV vaccinated class V at rate δ, while the remaining who can be infected with HBV and will move to the I H class with the force of infection (1 − δ)λ H . The vaccine-induced immunity acquired by vaccinated individuals is supposed to wane at rate π H and the way to vaccinated individuals to acquire HBV infection is through the waning of vaccine-induced protection, and individuals therefore enter the HBV acute infection class I H . Thus, HBV vaccinated individuals can experience break-through infection (due to incomplete protection provided by vaccine) and can become infected with HBV at rate π H λ H . We define by q the average probability that an individual in the HBV acute class I H fails to clear an acute infection but develops a chronic state (C H ). Then, individuals in the I H class progress to the C H class at rate qγ 1 , while the remainders enter the R H class at rate γ 1 (1 − q). Further, individuals in the C H class progress to the HBV recovered class (R H ), at rate γ 2 . Individuals in the I H , C H and R H classes are also reduced due to the TB infection (following effective contacts with individuals in the I T , I T I , I T C and I T R classes). The parameters ψ 1 , ψ 2 and ψ 3 (with ψ 3 < ψ 1 < ψ 2 ) account for the assumed increase in probability of acquiring TB infection for HBV-infected individuals alone. The parameters ψ 1 , ψ 2 and ψ 3 are associated, respectively, with those with acute infection (I H ), carrier state (C H ) and recovered state (R H ). It is assumed that individuals with HBV infection are more prone to TB infection than all susceptible individuals. Further, those with HBV chronic state acquire TB infection at a higher rate than those in the acute stage of HBV infection which also acquire TB infection at a higher rate than recovered individuals owing to the weaker immune status of the former. Once infected by Mycobacterium tuberculosis, individuals in the I H , C H and R H classes move to the E T I , E T C and E T R classes at rates ψ 1 (1 − γ 1 )λ T , ψ 2 (1 − γ 2 )λ T and ψ 3 λ T , respectively. Carriers are prone to the background death rate that applies to the whole community but have an additional death rate d H because of their hepatitis B carrier status.
The model variables and parameters are further described in Tables 1 and 2 for elucidation. HBV and TB induced death rate of individuals in the I T C class d 3T TB induced death rate of individuals in the I T R class d 4T HBV induced death rate of individuals in the E T C class r 2 TB recovery rate of individuals in the I T class r 2h
TB recovery rate of individuals in the I T I class r 2c
TB recovery rate of individuals in the I T C class r 2r
TB recovery rate of individuals in the I T R class r 1 Rate of TB effective chemoprophylaxis of individuals in the E T class r 1h Rate of TB effective chemoprophylaxis of individuals in the E T I class r 1c Rate of TB effective chemoprophylaxis of individuals in the E T C class r 1r Rate of TB effective chemoprophylaxis of individuals in the E T R class
The model
Putting the above formulations and assumptions together gives the following system of differential equations:
We assume that the population of new born carriers (born by carrier mothers) is less than the sum of the death of carriers and the population moving from carrier to immune state. In this case, we have µωv < µ 0 + d H + γ 2 . Otherwise, carriers would keep increasing rapidly as long as there is infection, i.e., dC H /dt > 0 for C H = 0 or I H = 0 and t ≥ 0.
The parameter values used for numerical simulation are given in Table 3 . 
Positivity of solutions
For the system (2.4) to be epidemiologically meaningful, it is important to prove that all its state variables are non-negative for all time. In other word, solutions of system (2.4) with positive initial data remain positive for all time t > 0. This can be verified as follows. Suppose, for example, the variable I H becomes zero for some timet > 0 , i.e., I H (t) = 0, while all other variables are positive. Then, from the I H equation we have dI H (t)/dt > 0. Thus, I H (t) ≥ 0 for all t > 0. Similarly, it can be shown that all variables remain nonnegative for all t > 0.
Invariant region
The TB-HBV transmission model (2.4) will therefore be analyzed in a suitable feasible region, obtained as follows.
We first show that all feasible solutions are uniformly-bounded in a proper subset of Ω. Let,
≥0 be any solution of the system with non-negative initial conditions. Adding all the equations in system (2.4) gives the following equation for N , the total populatioṅ
Then, one getsṄ < Λ + µ − µ 0 N . Thus, applying Birkhoff's and Rota's Theorem on differential inequality [43] , as t → ∞, one obtains 0 ≤ N ≤ Λ + µ µ 0 . Therefore, all feasible solutions of components of system (2.4) enter the region
(2.5) Thus, it follows from (2.5) that all possible solutions of system (2.4) will enter the region. Hence, the region Ω, of biological interest, is positively-invariant under the flow induced by system (2.4). Further, it can be shown using the theory of permanence [44] that all solutions on the boundary of Ω eventually enter the interior of Ω. Furthermore, in Ω, the usual existence, uniqueness and continuation results hold for system (2.4). Hence, system (2.4) is well posed mathematically and epidemiologically and it is sufficient to consider the dynamics of the flow generated by the system (2.4) in Ω.
Having established a biologically feasible region where the model is biologically and mathematically well-posed [45] , the next step is to consider the dynamics of the two sub-models, namely; HBV-only and TB-only models. This would help to lay down the foundation for the qualitative analysis of the full model.
Mathematical analysis of the HBV and TB sub-models
HBV-only sub-model
Hepatitis B is a potentially life-threatening liver infection caused by the HBV and is a major global health problem and the most serious type of viral hepatitis [3] . It has caused epidemics in parts of Asia and Africa. Worldwide, about 2 billion people have been infected with the virus and about 360 million live with this chronic infection. Estimated 600,000 persons die each year due to the acute or chronic consequences of hepatitis B [3, 46] .
The HBV-only model is obtained by setting
It should be pointed out that the HBV-only model is a slight modification of HBV models proposed in Refs. [11] [12] [13] [14] . In the model (3.1), we have assumed that the vaccine-induced immunity acquired by vaccinated individuals is suppose to wane and the way for vaccinated individuals to acquire HBV infection is through the waning of vaccine-induced protection, and individuals therefore enter the HBV acute infection class. This is no the case of the models proposed in Refs. [11] [12] [13] [14] where the authors have supposed that when the vaccine-induced immunity wanes, vaccinated individuals return to the susceptible before acquire HBV infection.
The feasible region for this sub-model is
Next, we show that the region Ω H is positively invariant, so that it is sufficient to consider the dynamics of the above model in Ω H . Adding all equations in (3.1) giveṡ
Since the right hand side of the above equation is bounded by Λ + µ − µ 0 N (t), it follows thaṫ
. Using a standard comparison theorem [47] [48] [49] , it can be shown that
then, either the solution enters Ω H in finite time, or N (t) approaches Λ + µ µ 0 asymptotically, and the infected variables I H , C H and R H approach zero. Hence, Ω H is attracting. One of the most important concerns in the analysis of epidemiological models is the determination of the asymptotic behavior of their solutions which is usually based on the stability of the associated equilibria [50] . These models typically consist of a disease-free equilibrium and at least one endemic equilibrium. The local stability of the disease-free equilibrium (DFE) is determined based on a threshold parameter, known as the basic reproductive number [51, 52] .
Local stability of the disease-free equilibrium (DFE) of the HBV-only model
The DFE of the HBV-only model (3.1) is given by,
, where
The local stability of the DFE of the HBV-onlymodel is determined by its basic reproduction number R H 0 , which is computed using the next generation operator method proposed by van den Driessche and Watmough [52] .
Using the notations in [52] , the matrices F and V , for the new infection and the remaining transfer, are, respectively, given by :
We can also interpret R 
Thus, a sufficiently effective HBV vaccination program can lead to effective disease control if it results in making the right-hand side of (3.4) less than unity, that is,
Further, sensitivity analysis on the vaccination parameter of susceptible individuals is carried out by computing the partial derivative of R H 0 with respect to δ yielding ∂R
Thus, increasing the vaccination parameter δ will have a positive impact in reducing the propagation of HBV in the community. To find better control strategies for HBV infection, we would like to see what parameters can reduce the basic reproduction ratio R Table 3 . From Fig. 2(a) , we can see that R H 0 decreases if β H decreases (see Fig. 2(a) ) even in the case of large values of 1 − ω. This means that if the transmission coefficient β H is sufficiently small HBV infection could be eliminated even if 1 − ω = 0. Also, it clearly appears from Fig. 2(b) that R H 0 decreases if δ increases or β H decreases. However, it is difficult to control β H . Figure 2(c) shows the effects of δ and 1 − ω on the basic reproduction ratio R H 0 when β H = 5. As expected, R H 0 might be smaller than 1 as long as δ and 1 − ω are large enough. Therefore, immunization of both newborns and susceptible individuals is an efficient intervention. Thus, combining immunization with reduction of contacts can reduce R H 0 to be less than 1. Then, the optimal control strategy will be a combination of immunization of newborns, immunization of susceptible individuals (at least young adults), and reduction of contacts. Table 3 .
Global stability of DFE of the HBV-only model
We get the following result concerning the stability of the DFE Q H 0 of system (3.1). 
where
Its time derivative along the trajectories of system (3.1) satisfieṡ
(3.7)
Since the state variables of the model when the HBV is endemic in the population do not exceed the state variables of the model in a population free of HBV, one has that
Now, plugging the positive constants a 1 and a 2 given in Eq. (3.6) into Eq. (3.8), one finally obtainṡ
Thus,L ≤ 0 when R H 0 ≤ 1. By LaSalle's invariance principle, the largest invariant set in Ω H contained in {(S, V, I H , C H , R H ) ∈ R 5 ≥0L = 0} is reduced to the DFE. This proves the global asymptotic stability on Ω H ( [55, Theorem 3.7.11, page 346]). Since Ω H is absorbing, this proves the global asymptotic stability on the nonnegative orthant when R H 0 ≤ 1. We stress the need to consider a positively invariant compact set to establish the stability of the DFE since the function L is not positive definite. Generally the LaSalle's invariance principle only proves the attractivity of the equilibrium. Considering Ω H permits us to conclude for the stability [53] [54] [55] . This fact is often overlooked in the literature using the LaSalle's invariance principle. This concludes the proof.
2 Figure 3 shows simulation results converging to the disease free equilibrium for the total number of HBV infected individuals using various initial conditions when β H = 10 (so that R H 0 = 0.5805). All other parameters are as in Table 3 . This result shows that HBV can be eliminated from the community if the associated threshold quantity, R H 0 , can be brought to a value less than unity. Table 3 .
Existence and stability of the endemic equilibrium
Because R H appears only in the fifth equation of the model, we can discuss the steady states without this variable. To find conditions for the existence of an endemic equilibrium for which HBV is endemic in the population (i.e., at least one of 
Solving the above equations in (3.11) at steady state gives
Substituting (3.12) in (3.10), it can be shown that the non-zero equilibria of system (3.1) satisfy the following quadratic equation in term of λ * H :
where 
A simple calculation proves that f (β H (1 + η) > 0 . It is now a trivial matter to see that f (0) < 0 when R Now, let us study the stability of the endemic equilibrium guaranteed by Lemma 3. Using standard linearization of the HBV-only model around the endemic equilibrium is laborious and not really tractable mathematically. Here, the center manifold theory [56] , as described in [57] (Theorem 4.1), will be used to establish the local asymptotic stability of the endemic equilibrium (see also [52, 58] ).
Then, we claim the following result (the proof is given in Appendix A): Figure 4 shows convergence to the endemic equilibrium for the total number of infected individuals using various initial conditions when β H = 20 (so that R H 0 = 1.1609). All other parameters are as in Table 3 .
In summary, the HBV-only model (3.1) has a globally-asymptotically stable DFE whenever R H 0 ≤ 1, and a unique endemic equilibrium point whenever R H 0 > 1. The unique endemic equilibrium point is LAS at least near R H 0 = 1. The dynamics of TB-only is also explored as below.
TB-only sub-model
The high prevalence of tuberculosis in developing countries and recent resurgence of tuberculosis in many developed countries suggest that current control strategies are suboptimal. More than 36 million patients have been successfully treated via the World Health Organization strategy for tuberculosis control since 1995. Despite predictions of a decline in global incidence, the number of new cases continues to grow, approaching 10 million in 2010 [1, 2] . This rise has been attributed Table 3 .
to the spread of HIV, the collapse of public health programs and the emergence of drug-resistant strains of M. tuberculosis. Another issue that is essential to the epidemiology of TB is the exogenous re-infection, where a latently-infected individual acquires a new infection from another infectious (see [34, 61] and references therein).
The TB-only model is obtained by setting 15) where λ T = β T I T N and N = S +E T +I T . Note that since the population is free of HBV, there is no HBV infected individuals who can transmit HBV infection to susceptible individuals. Therefore, it is not necessary to vaccine people with respect to HBV. So, in this case, one has δ = ω = 0. We point out that the TB-only model (3.15) is an extension of the model proposed by Kirchner et al. [66] , which, in our opinion, captures the essentials of Mycobacterium tuberculosis transmission. In our model, exogenous reinfections have been take into account.
Likewise Ω H above, it can be shown that all solutions of system (3.15) starting in Ω T remain in Ω T for all t ≥ 0. Thus, Ω T is positively invariant (hence, it is sufficient to consider the dynamics of (3.15) in Ω T ).
Local stability of the DFE of the TB-only model
The TB-only model (3.15) has a DFE given by
The stability of this equilibrium will be investigated using the next generation operator method [51, 52] . Using the notations in [52] on system (3.15), the matrices F and V , for the new infection terms and the remaining transfer terms are, respectively, given by
The spectral radius or the largest eigenvalue of its next generation operator is given by
Thus, from Theorem 2 in [52] , the following result holds. Figure 5 shows the effects of the chemoprophylaxis rate r 1 and the treatment rate r 2 on the basic reproduction ratio R T 0 when β T = 0.5. All other parameters are as in Table 3 . As expected, when r 1 is fixed, the basic reproduction ratio, R T 0 , decreases as r 2 increases and vice versa. Then, combining the chemoprophylaxis of latently infected individuals and treatment of infectious can reduced R T 0 to less than unity. Therefore, the best control strategy will be the chemoprophylaxis of latently infected individuals and treatment of infectious or a combinaison of chemoprophylaxis and treatment.
The threshold quantity R T 0 is the reproduction number for TB. Biologically speaking, Lemma 4 implies that TB can be eliminated from the community (when R T 0 < 1) if the initial size of the sub-populations of the model is in the basin of attraction of Q T 0 . Since TB models may undergo the phenomenon of backward bifurcation (see [58] and references therein), it is instructive to determine whether the present sub-model exhibits this phenomenon. Table 3 .
Existence of backward bifurcation
System (3.15) has one disease-free equilibrium, Q T 0 = (S 0 , 0, 0) and one or two endemic equilibria of the form Q *
On the other hand, from Lemma 4, the DFE of the TBonly model is locally asymptotically stable (LAS) if R T 0 < 1. However, this equilibrium may not be globally asymptotically stable (GAS) in Ω T for R T 0 < 1, owing to the possibility of backward bifurcation, where the stable DFE co-exists with a stable endemic equilibrium when R T 0 < 1 (see for instance [58] [59] [60] [61] [62] [63] [64] [65] ) and references therein). In general, substitution of standard incidence with mass action incidence in some differential models removes their backward bifurcation property [63] . The standard incidence together with a large disease induced death rate are the driving force herein. The public health implication of backward bifurcation is that the classical requirement of having the basic reproductive number less than unity, although necessary, is no longer sufficient for curtailing the outbreak of the disease [64] . The possibility of this phenomenon in (3.15) is investigated below. Solving the TB-only model at an arbitrary equilibrium Q * 18) where A 1 and A 2 are defined as in Eq. (3.17), and
is the force of infection at the steady state. Solving the equations in (3.18) at the steady state gives
Substituting the expressions in (3.20) in Eq. (3. 19) , it can be shown that the non-zero equilibria of the system (3.15) satisfy the following quadratic equation in term of λ * T :
where It should be pointed out that the case (iii) indicates the possibility of a backward bifurcation phenomenon (where locally asymptotically stable DFE co-exists with a locally asymptotically stable endemic equilibrium when R T 0 < 1, (see for instance, [58] [59] [60] [61] [62] [63] [64] ) in system (3.15) with TB alone. To check this, the discriminant c where Table 1 .
The associated backward bifurcation diagram is depicted in Fig. 6 . The backward bifurcation phenomenon is also illustrated by simulating the system (3.15) with different initial conditions, parameters of Table 3 and β T = 1 (so that R T 0 = 0.8733). Figure 7 shows the convergence to both the disease-free equilibrium and the endemic equilibrium for the trajectories of system (3.15) when R T 0 < 1. In other words, from this figure, the profiles can converge to either the disease free equilibrium or an endemic equilibrium point, depending on the initial sizes of the population of the model (owing to the phenomenon of backward bifurcation).
Finally, it is worth stating that, unlike in the HBV-only model, the DFE of the TB-only model (Q 
Analysis of the full HBV-TB model
Having analyzed the dynamics of the two sub-models, that is HBV-only and TB-only models, the full HBV-TB model (2.4) is now considered (the analysis is done in the positively invariant region Ω).
Local stability of the disease-free equilibrium
The HBV-TB model (2.4) has a DFE given by are independent and given in terms of HBV and TB-only associated reproduction numbers (see details in Appendix B). It is therefore evident that the associated reproduction number for the full HBV-TB model denoted by R 0 is given by
where Table 3 .
It is worth noting that the DFE of the HBV-TB is not GAS, owing to the presence of the TBinduced backward bifurcation. Like in the case of the TB-only model (3.15), the full HBV-TB model (2.4) also undergoes a backward bifurcation phenomenon. 
Impact of HBV on the prevalence level of TB infection
In many epidemiological models, the magnitude of the reproduction number is associated with the level of infection. The same is true in the model (2.4) . That is, the basic reproduction numbers for TB and HBV infections, R Table 3 except that r 2h = r 2c = r 2r = 0.5r 2 (i.e., it takes twice as long to treat a TB infected person with HBV than without). Figure 14 plots the fraction of active TB (I T + ε(I T R + ε t I T I + ε c I T C )/N and the fraction of HBV acute and chronic carriers
Figures 14(a) and 14(b) present the results of the numerical simulation for different values of k, k c , k h and k r . It clearly appears that increase the parameters k, k c , k h and k r due to TB has no effect on the prevalence levels of HBV and TB. This illustrates that the assumption k c > k h > k r > k does not automatically lead to an increase in TB prevalence. One of the reasons is that a person with both HBV acute and TB infection (E T I and I T I ) may progress at a faster rate (q 1 > q 2 ) to the both HBV chronic and TB infection (E T C and I T C ) which is associated with an excess death rate Table 3 .
Other factors may also play an important role, e.g., the probability that individuals who are also infected with TB in the HBV acute infection fail to clear an acute state and develop a carrier state (q 1 and q 2 ).
Influence of TB on HBV dynamics
Our numerical simulations also suggest that the presence of TB may have a significant impact on HBV dynamics. Simulation results are demonstrated in Fig. 14. This figure shows time plots of (I T + ε(I T R + ε t I T I + ε c I T C )/N (fraction of active TB) and
/N ( fraction of HBV acute and chronic carriers) for different values of q, q 1 and q 2 (probability that an individual in the HBV acute infection fail to clear an acute state and develops a carrier state). Other parameter values are the same as in Fig. 14 . Figure 15 (a) is for the case of q = q 1 = q 2 (i.e., the probability that an individual in the HBV acute infection fail to clear an acute state and develops a carrier state is the same for a person with or without TB infection), while Fig. 15(b) is for the case of q 1 = 10q and q 2 = 2q (i.e., for HBV Table 3. dually infected individuals with TB infection, the progression from acute stage to chronic stage of infection is respectively ten and two times faster than a person without TB infection). It shows that the increased the parameters q 1 and q 2 due to TB have increased the prevalence levels of HBV and TB. This means that condition q 1 > q 2 > q alone may be sufficient for TB to have a significant impact on HBV.
Discussions
A realistic deterministic ODE based compartmental model for the transmission of hepatitis B and tuberculosis co-dynamics in a population has been proposed and analyzed. The HBV-only and TB-only models were qualitatively examined, first of all. The main theoretical results obtained are as follows:
1. We are able to compute independent reproduction numbers for TB (R Table 3. 2. The HBV-only model has a globally-asymptotically stable disease-free equilibrium whenever a certain epidemiological threshold (R H 0 ) is less than unity and unstable if this threshold exceeds unity; 3. The HBV-only model has a unique endemic equilibrium whenever the aforementioned threshold exceeds unity. This endemic equilibrium is locally asymptotically stable at least near R H 0 = 1 whenever it exists;
4. Unlike the HBV-only model, the TB-only model undergoes the phenomenon of backward bifurcation, where the associated stable disease-free equilibrium co-exists with a stable endemic equilibrium when the corresponding reproduction number (R T 0 ) is less than unity;
5. The full HBV-TB model is shown to have a locally-asymptotically stable disease-free equilibrium when its reproductive threshold is less than unity, and unstable if the threshold exceeds unity. It also undergoes the phenomenon of backward bifurcation under certain conditions; Table 3 except that r 2h = r 2c = r 2r = 0.5r 2 (i.e., it takes twice as long to treat a TB infected person with HBV than without).
The simulation results provided many interesting insights into the effect of the dynamical interactions between TB and HBV. Mainly, the following are observed:
(i) The HBV only sub-model has a DFE which is GAS.
(ii) The analysis shows that the TB-only model exhibits a mechanism known as backward bifurcation by allowing for reactivation of latent TB individuals by infected individuals.
(iii) The two diseases disappear in the population whenever their reproduction numbers are very small and less than unity.
(iv) The HBV-free equilibrium is stable when R T H > 1 and R H 0 < 1. However, the symmetric result does not hold. That is, the TB-free equilibrium may not be stable when R which of the numbers is larger).
(vi) Condition k c > k h > k r > k alone does not always lead to a significant increase in TB in the presence of HBV. However, when σ c > σ h > σ r > σ, the presence of HBV may have a significant influence on TB dynamics. Also, when q 1 > q 2 > q, the presence of TB may have a significant influence on the HBV dynamics.
Numerical results suggest that to reduce or control the impact of TB, investing more in reducing the prevalence of HBV can be an effective option. Such reductions would not be easy due to the waning vaccine-induced immunity and lack of effective medication. There is no 'cure' at this time for HBV. However, significant reductions may be obtained through programs that accelerate the treatment of active TB cases. Since there are about 8 million new cases of active TB per year, a program may be feasible. It has worked well in countries that allocate substantial resources to public health. Naturally, accelerating the treatment rate of individuals with active TB is more critical in areas where HIV prevalence is high since approximately 10% of the HIV-infected population worldwide is infected with HBV. Unfortunately, the areas with the highest prevalence of co-infections have limited resources and cannot implement to accelerated TB treatment programs.
It is worth stressing that our models and observations are rather crude for multiple reasons. The results are not only based on local mathematical analysis but they are from a model that does not incorporate multiple and common forms of the possibility of increases in antibiotic resistant TB, and the impact of human behavior, particularly the role of core groups (prostitution, injection drug, etc.). A research program that tackles some of these possibilities is still viable, since it is the first time the dynamics of HBV-TB co-infection is studied and therefore they are still poorly understood from a theoretical or mathematical perspective. 
